Safety Study of High Doses of Zinc in ALS Patients

NCT01259050 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Zinc and Copper

Sponsor

Phoenix Neurological Associates, LTD